Clinical trial
Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in…
NCT00266656 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00266656 |
|---|---|
| Title | Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome |
| Official title | Effect of Early Growth Hormone Treatment on Long-term Growth and Skeletal Maturation in Girls With Turner Syndrome |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Turner Syndrome |
| Intervention type | Drug |
| Interventions | Humatrope |
| Enrollment | 69 |
| Start date | Dec 1, 2005 |
| Primary completion | Sep 1, 2015 |
| Completion | Sep 1, 2015 |
| First posted | Dec 19, 2005 |
| Last update posted | Mar 31, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: